Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.74 USD | -0.36% | 0.00% | +9.60% |
03/06 | Oncocyte Corporation Announces Promising Results in A Phase 2 Clinical Trial | CI |
30/05 | Oncocyte Corporation Announces Favorable Oncocyte Vitgraft Kidney Study Results | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.60% | 3.66Cr | |
-41.97% | 792.19Cr | |
-4.31% | 217.71Cr | |
-21.69% | 196.83Cr | |
-24.94% | 157.87Cr | |
+31.45% | 114.37Cr | |
+26.75% | 79Cr | |
-9.83% | 69Cr | |
-26.33% | 53Cr | |
+3.38% | 30Cr |
- Stock Market
- Equities
- OCX Stock
- News OncoCyte Corporation
- Transcript : OncoCyte Corporation - Special Call